Effects of Gait Training With Assistance of a Robot-Driven Gait Orthosis in Hemiparetic Patients After Stroke

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2007 by Samsung Medical Center.
Recruitment status was  Recruiting
Information provided by:
Samsung Medical Center
ClinicalTrials.gov Identifier:
First received: September 13, 2007
Last updated: NA
Last verified: May 2007
History: No changes posted
The purpose of this study is to investigate the effects of robot-assisted gait training on active walking in the patients with stroke.

Condition Intervention
Procedure: Robot-assisted gait training

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Samsung Medical Center:


Ages Eligible for Study:   16 Years to 80 Years
Genders Eligible for Study:   Both

Inclusion Criteria:

  • 1st-ever-stroke
  • hemiplegic patient after stroke
  • who can stand independently, but cannot walk more than 10 meters independently
  • whose muscle powers of hip and knee are more than poor on manual muscle test

Exclusion Criteria:

  • previous gait difficulty before stroke onset
  • arthralgia on lower extremity
  • uncontrolled hypertension or hypotension
  • severe medical illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00530543

Contact: Yun-Hee Kim, MD, PHD 82-2-3410-2818 yunkim@smc.samsung.co.kr

Korea, Republic of
Samsung Medical Center Recruiting
Seoul, Korea, Republic of, 135-710
Contact: Yun-Hee Kim, MD, PHD    82-2-3410-2818    yunkim@smc.samsung.co.kr   
Sponsors and Collaborators
Samsung Medical Center
Principal Investigator: Kyung Hoon Jeong, MD Samsung Medical Center
  More Information

ClinicalTrials.gov Identifier: NCT00530543     History of Changes
Other Study ID Numbers: 2007-01-039 
Study First Received: September 13, 2007
Last Updated: September 13, 2007
Health Authority: South Korea: Institutional Review Board
South Korea: Korea Food and Drug Administration (KFDA)

Keywords provided by Samsung Medical Center:

ClinicalTrials.gov processed this record on May 30, 2016